The worldwide biomarkers market is predicted touch 59.1 billion US dollars by the end of year 2022 from year 24.5 billion US dollars in year 2014 at a CAGR growth rate of 15.99%. Growing expenditure on health care and research & development activities plus enhanced utility of biomarkers for diagnostics are predicted to stimulate the growth of the global biomarkers market. The growth and expansion of the industry will also be supported by the low prices of clinical trials in emerging nations and new initiatives taken by the firms who are into the biomarker research business.
Biological safety cabinets or biosafety cabinets include a variety of devices that are equipped with High-efficiency particulate arrestance (HEPA) filters. These containment equipment provide personnel and environment protection form biohazardous constituents.Biological safety cabinets are classified based on specifications based on airflow patterns and velocities, exhaust systems and construction.
Growing prevalence of sports injuries, and elbow tendon bumps, joint pain are the key factors that have urged the advent of tennis elbow market. In the next few years the demand for tennis elbow treatment is expected to increase significantly in the emerging economies such as China and Canada.
Growth in incidence of rectal, GI and colon cancer and flourishing trend of cancer screening through genetic testing are the prime factors allowing the growth of in vitro colorectal cancer screening market. Favorable government guidelines and regulation for increasing awareness in the general population and supporting the adoption colon cancer screening also facilitate the global demand for minimally invasive screening tests that use genetic biomarkers and DNA for risk determination.
Rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in clinical as well as industrial settings. In the next few years the demand for rapid microbiology tests is expected to increase significantly in the emerging economies such as China and India.
Rapid microbiology tests, also known as alternative microbiological methods, are the technologies that allow the user to get microbiology test results faster compared to the traditional culture-plate methods. Rapid microbiology testing provides the qualitative, quantitative, and identification results. In the next few years the demand for rapid microbiology tests in food and beverages industry is expected to increase significantly in the emerging economies such as China and India.
Rapid microbiology tests, also known as alternative microbiological methods, are the technologies that allow the user to get microbiology test results faster compared to the traditional culture-plate methods. Rapid microbiology testing provides the qualitative, quantitative, and identification results. In the next few years the demand for rapid microbiology tests in pharmaceutical industry is expected to increase significantly in the emerging economies such as China and India.
Hybrid operating rooms are extremely complex working environments where a large team of surgeons, interventionalists, nurses, anesthesiologists, and technicians need to work seamlessly together. A hybrid OR (Operating Room) is an alternative to conventional OR equipped with advanced medical imaging systems and devices supporting high quality interventional imaging and minimally invasive surgeries. In the next few years the demand for hybrid operating room is expected to increase significantly in the emerging economies such as China and India.
Conventional wound healing turns out unproductive in healing acute wounds such as deep cuts, burn injuries, and chronic ulcers. Introduction of bioactive wound care products has efficiently provided solution to treat such critical wounds and injuries. Bioactive wound dressings control infection and hasten healing process, reduce the risk of leakage, alleviate pain and discomfort. Materials such as chitosan, alginates, keratin, hydrocolloids and collagen are often the key constituents of bioactive wound dressings.
Bioengineered skin and soft tissue substitutes are generally derived from autologous or allogeneic human tissue, xenographic tissue, synthetic materials or a composite.These products being used and evaluated for treating a variety of conditions such as breast reconstruction, thermal injury treatment, plastic surgeries, lower extremity ulcers and others. Bioengineered and soft tissue substitutes can either be acellular or cellular.
Biological safety or biological safety cabinets are widely used containment devices geared with HEPA filters to provide personnel, product and environmental protection from biohazardous material. Based on the level of protection offered, such cabinets are largely classified into Class I, II, or III specifications, also with respect to airflow velocities, construction, exhaust systems and patterns.
The Global Single-use Bio-processing Systems market is expected to witness significant growth during the forecast period primarily by the growing demand and cost- effective features of these single-use systems, which are mostly used in R&D applications. The essential bio-processing systems used in R&D applications are disposable bioreactors, mixers, containers, tubing, connectors, sampling systems, purification devices and columns, and probes/sensors.
The purpose of this strategic research study titled “Cell Culture Media and Reagents Market- Growth, Future Prospects and Competitive Analysis, 2016 – 2023” is to offer industry investors, company executives, and industry participants with indepth insights to enable them make informed strategic decisions related to the opportunities in the cell culture media and reagents market.
Digital Polymerase Chain Reaction (dPCR) is a technologically advanced version of traditional polymerase chain reaction (PCR). dPCR is more sensitive and reliable technique with improved ability to quantify the absolute amount of nucleic acid. It divides the sample into large number of fragments, each containing either one or no template nucleic acid sequence.
ADME is the abbreviation for absorption, distribution, metabolism and elimination, a pharmacology and pharmacokinetics term that describes the disposition of a drug or compound inside the human body. ADME comprises set of four processes that develop the performance of a drug on human tissue and ADME toxicology testing is applied for the development of a new drug.
Antioxidants is chemical which neutralize the free radical thus inhibiting the oxidation of the other molecule, further delaying or preventing the damage to the cells. It can be artificial or natural antioxidant such as vitamin A, vitamin C, Vitamin E, BHT, BHA etc
Starter culture contain deliberately added microorganism, to initiate fermentation process. Starter culture present in liquid, dried, or in frozen form. These starter culture is key ingredient in fermentation industries where alcoholic and non-alcoholic beverage (cereal based, fruit based drinks and kombucha), probiotic are manufactured. They also play an important role in dairy, baking and cheese manufacturing industries.
Pharmacogenomics refers to the study of the human genetic make-up and corresponding tailoring of the drug treatment. Each individual response to the drug varies according to the genetic composition. To address such variations, it is necessary to study how the drug processing is affected by the genes. Precise genetic testing helps in determining targeted drug therapies and streamline the treatment protocol to improve therapeutic results.
Join Credence analysts to explore the latest IT Trendsview upcoming webinars
Global Biotechnology Market Analysis
The worldwide biotechnology market was forecasted to cross 3,20,000 million dollar mark by end of year 2015 as per the reports provided by global market analysts. Industrial growth is propelled by economic recovery, enhanced research & development funding, biotechnology and government initiatives utilized in medical sciences and agriculture. Emerging economies like India and China are becoming key business market sectors in the fields of industrial biotechnology and agricultural biotechnology.
The economic crises adversely affected the biotechnology industry and brought decline in profits in European Union and USA owing to limited wealth inflows and projects delay or cancellation. The industry has entered the recovery stage with most of the biotechnology outfits producing profits due to new cost effective and money saving measures.
Business funding is on the rise on the flipside of more positive financial conditions, although this funding is focused in a less proportion of bigger outfits. Smaller firms are still struggling to increase research and development funds. The condition is predicted to increase as venture capitalists exercise higher caution in looking for more secured investment choices.
Key Market Sections
The global genetic testing market was predicted to touch 4000 million dollar mark by the end of year 2015. Genetic testing for cancer is predicted to observe one of the highest rates of growth, getting specific interest from private section and scientific population at large. Direct to customer genetic testing is a market section that is expected to take off with most of the new outfits on the industry. Industry shapers includes deCODE and 23andme.
Geographical Market Share
United States of America dominated the worldwide biotechnology market. It was succeeded by European Union which included developed countries like France, Germany, UK and Spain as per the reports provided by global market analysts. Emerging economies such as India and China are predicted to register strong growth in industrial biotechnology as well as in agricultural biotechnology markets owing to rise in levels of disposable incomes and rise in population. Both these Asian nations are playing growingly vital part in the market of biotechnology medicines and drugs on the flipside of relatively low financial investment accompanied by high expertise level.
As per the global market analysts the growth in the global biotechnology market is predicted to be stimulated by enhanced healthcare services, improved healthcare infrastructure and rising interests of private sector industries in making maximum utilization of information technology to carry out their tasks, work & daily job activities. It is predicted that there merger and acquisitions events are likely to grow in future. It will be stimulated by blockbuster medicine patent expiration and healthcare rules put in place to regulate expenditure. Minor outfits are expected to divest their businesses to bigger outfits or depend upon in-licensing partnerships with more monetarily secured outfits owing to investment restrictions.
Technical modernizations, increase in stringent rules, public awareness and intellectual property rights are few of the aspects that will positively affect the biotechnology segment. Biotechnology uses and applications will continue to rise along with agricultural sector, medical sector, environmental sciences section, health sector and food segment as key end use domain segments .
Business investments in biotechnology sector will constantly strive and aim at making new medical discoveries, make new breakthroughs in methods of medical treatments and use or apply new methods of treatments in field medical research & development. This sector is led by specializations in field of inflammation, oncology and cardiology. Curative categories which includes hormone treatment and treatment for diabetes will receive enhanced focus from companies involved in business of biotechnology in relation and response to growing demand for these treatments from biotechnology market sectors .